AstraZeneca Shares Slip After HSBC Cuts Rating Following Wainua Setback (AZN)

negativeWainuaNegative

AI Analysis

Summary

HSBC cut its rating on AstraZeneca following a setback with the Wainua program, resulting in a decline in the company's share price. The specific details of the Wainua setback are not provided in the article.

Outcome Details

Wainua setback

Importance:5/10

Sentiment:

-0.60

analyst downgraderating cutprogram setbackstock decline

Related Companies

$AZN

Read the original article

Published by yahoo_finance on July 13, 2026 12:32 PM

Read Original